Zidometacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H16N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 446VQG66LC, chemically known as 1h-indole-3-acetic acid, 1-(4-azidobenzoyl)-5-methoxy-2-methyl- but generally known as zidometacin, which bears US NIH Compound Identifier 44179. European Medicines Agency schedules Zidometacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00152MIG. The term ZIDOMETACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). ZIDOMETACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zidometacin under HS 29339990 and SITC 51577. As of Q4 2014, ZIDOMETACIN remains the US FDA Preferred Term for this commodity. Zidometacin bears US NLM identifiers UMLS ID C0078765 and NCI Concept Code C66691. SMILES: O(C1CC2C(C(N(C2CC1)C(=O)C1CCC(N=[N]=N)CC1)C)CC(=O)O)C.